The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses that possess capabilities to conduct innovative research that will contribute toward meeting the program objectives of the agencies.
Highlighted topic areas include:
- Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases
- Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern
- Development of Nanoparticle Dengue Diagnostic Tests
- Aerosolized Delivery of Anti-Tubercular Drugs
- Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs
- Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs
- Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety
- Development of User-Friendly Diagnostics of Arboviral Infections in Resource-Limited Settings
- Visualizing Knowledge about Human Health and the Pathways of Translation
- Automated Instrument to Clean Microtiter Plates
- Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies
- Improving Safety and Efficacy of Red Blood Cells for Transfusion
- Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging
- Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization
- Thermostable Dry Measles Vaccine Formulation for Sublingual Administration
This activity, as part of the Small Business Innovation Research (SBIR) program, is designed to stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research needs; and increase the commercial application of Federally-supported research results.
Additional topics are available under PHS-2013-1. The agencies will post a full solicitation on or about August 15, 2012 and begin accepting proposals at that time. The deadline for submission is November 13, 2012.